Mia Brundin

Mia Brundin has a diverse work experience spanning different roles and industries. Mia most recently served as the CEO of Synartro starting in July 2020. Prior to that, they worked at Mylan as the Country Manager from November 2016 to July 2020.

Before their time at Mylan, Mia held several positions at Meda AB. Mia served as the Country Manager from August 2013 to October 2016. Prior to that, they were the Head of Nordic Project Management from January 2008 to August 2013, where they led a team and focused on initiating and executing projects to contribute to organic growth. Mia also held the role of Marketing Manager in the Nordic Marketing team from January 2008 to April 2009, where they led a team and coordinated major brands and product development for the Nordic and EU regions.

Prior to Meda AB, Mia worked at Recip AB, where they held various roles. Mia served as the Marketing Manager of Nordic Marketing from April 2007 to January 2008, overseeing the coordination of international brands and having strategic responsibility for branding and growth. Before that, they were the Product Group Manager and Business Development Manager from January 2005 to April 2007, focusing on improving the cost benefit ratio and expanding the generic portfolio. Mia also served as a Product Manager from October 2000 to January 2005, where they had Nordic strategy and budget responsibilities for five brands and supported sales teams with sales material and product knowledge. Additionally, they briefly served as the National Sales Manager (temporary) from January 2001 to August 2001, leading a team of sales reps in Sweden.

Mia's early career includes roles at AstraZeneca, where they worked as an Area Sales Manager from January 1998 to October 2000, leading a team and developing campaigns. Prior to that, they worked as a Product Specialist from August 1994 to January 1998, focusing on sales for Losec in Stockholm and providing education to doctors about gastrointestinal subjects.

In summary, Mia Brundin has extensive experience in leadership, management, marketing, and sales roles within the pharmaceutical industry.

Mia Brundin has a diverse educational background. Mia pursued their higher education from 1990 to 1995 at Linköping University, where they earned a Master of Science degree in Business Administration and Economics. Their focus during this period was on the International Business Program, with a specialization in Marketing and German.

Their educational journey also included a brief stint in 1994 at Linköping University, where they explored the field of International Marketing from a German perspective. In 1993, they had the opportunity to enrich their knowledge further by attending courses at the Royal Melbourne Institute of Technology (RMIT) in Australia. The subjects they studied there included Industrial Marketing, International Marketing, Strategic Marketing Planning, and Distribution Channels.

Before their university studies, Mia Brundin attended Västergårdsgymnasiet in Södertälje from 1986 to 1988. Here, they pursued the Naturvetenskaplig linje or Science line, emphasizing a scientific education.

Overall, Mia Brundin's education demonstrates their passion for international business, marketing, and science. Their diverse academic background suggests a well-rounded individual with a broad range of knowledge and skills.